Introduction The objective of this study was to investigate the epidemiology of dietary supplement exposures in the USA. 9% of all exposures, followed by botanicals (31.9%), hormonal products (15.1%), and other supplements (5.1%). The majority of dietary supplement exposures (70.0%) occurred among children younger than 6 years old and were acute (94.0%) and unintentional (82.9%). Serious medical outcomes accounted for 4.5% of exposures and most (95.0%) occurred among individuals 6 years and older. Ma huang products, yohimbe, and energy products were the categories associated with the greatest toxicity.
Introduction
The United States (US) Dietary Supplement Health and Education Act of 1994 defines dietary supplements as products (excluding tobacco) intended to supplement the diet by increasing total dietary intake and/or providing one or more of the following: vitamins, minerals, herbs, botanicals, or amino acids [1] . The definition also includes concentrates, metabolites, constituents, or extracts of these ingredients. Dietary supplement use in the US has increased over the past several decades, with an estimated 42% of adults using at least one dietary supplement in 1988-1994, compared with a peak of 54% in [2003] [2004] [2005] [2006] [2, 3] . In 2011-2012, an estimated 52% of adults in the US reported having used a dietary supplement within the past 30 days [3] . Consumers often believe that dietary supplements are held to the same safety and efficacy standards as over-thecounter medications; however, dietary supplements are not considered drugs, and are not required to undergo clinical trials or obtain approval from the US Food and Drug Administration (FDA) prior to their sale in the US, unless the product is intended for therapeutic use, such as treating or preventing disease [4] [5] [6] . This lack of federal oversight has led to inconsistencies in the quality of dietary supplements, product mislabeling, and contamination with other substances [5, 7] .
Previous studies have used the National Poison Data System (NPDS), and its predecessor, the Toxic Exposure Surveillance System (TESS), to describe the characteristics of calls to poison control centers (PCCs) reporting dietary supplement exposures and toxicity [8] [9] [10] [11] [12] . Others studies have focused on emergency department visits resulting from adverse effects related to dietary supplement exposures [13] . The objective of this study was to provide an epidemiological description of dietary supplement exposures reported to PCCs in the US over a 13-year period. Unlike prior studies that focused on specific dietary supplements, included small sample sizes, or were conducted more than 10 years ago, the current study uses the NPDS database to investigate all dietary supplement exposures resulting in calls to PCCs in the US from 2000 through 2012 [8] [9] [10] [11] [12] [13] .
Methods
Dietary supplement exposure data from 2000 through 2012 were obtained from the NPDS, which is maintained by the American Association of Poison Control Centers (AAPCC) and contains reported detailed data from telephone calls about substance exposures received by regional PCCs in the US and its territories [14] . PCC specialists input data from each call into the NPDS database using a coding system and strict quality control protocols. This database can then be queried to obtain data about these reported exposures. For this study, the term Breported exposureŵ ill be referred to simply as Bexposure^for brevity.
Case Selection Criteria
All single-substance, dietary supplement exposure cases involving humans were extracted from the NPDS database using the generic codes listed in the Table 5 . Cases were excluded if the medical outcome was determined by the PCC specialist to be a Bconfirmed non-exposure^or Bunrelated effect.^Exposures occurring at a health care facility (HCF) were excluded from the analyses, but treatment at a HCF postexposure was not a cause for exclusion.
Variables
Data were analyzed by dietary supplement category, exposed person's age and gender, reason for exposure, chronicity of exposure, route of exposure, exposure site, management site, clinical effect, level of health care received, therapy received, and medical outcome. The dietary supplement categories created by the AAPCC were used in this study and include the following: amino acids, botanicals, cultural medicines, energy products, hormonal products, miscellaneous dietary supplements, and other dietary supplements (Table 5 ). In the botanicals category, ma huang (single ingredient) and multi-botanicals with ma huang were grouped into ma huang products for sub-analysis. Generic codes for energy products were introduced into the NPDS in mid-2010 and include both energy products and energy drinks. Other variable categories also followed AAPCC definitions [14] . The AAPCC classifies medical outcomes as minor, moderate, or major. BMinor effect^corresponds to minimal symptoms; Bmoderate effect^signifies more pronounced, prolonged, or systemic symptoms, usually requiring some form of treatment; and Bmajor effect^corresponds to lifethreatening symptoms or significant residual disability or disfigurement. In this study, moderate effect, major effect, and death categories were collectively defined as Bserious outcomes.^Exposures were grouped by exposed person's age into <6 years, ≥ 6 years, and unknown age. Reasons for exposure were classified as unintentional, intentional, adverse reaction, and other/unknown.
Statistical Analyses and Ethical Considerations
SPSS 21.0 (IBM Corp., Armonk, NY) and SAS 9.3 (SAS Institute Inc., Cary, NC) software were used for statistical analyses, and the descriptive statistics reported in this article include all dietary supplements. Because population data on the use of dietary supplements were not available, exposure rates were calculated using the US Census Bureau July 1st intercensal and postcensal population estimates for 2000-2012 [15] . Based on the scatterplot of the annual exposure rate (Fig. 2 ), there were changes in the directionality of the overall rate and the rates associated with ma huang and homeopathic agents. Therefore, piecewise linear regression models were used to analyze these trends. For each piecewise linear regression model, exposure rate was the response variable and year of exposure, parametrized by the time period segments, were the predictors. To clearly describe the trend without the effects of the FDA's 2004 ban on ma huang, a separate trend analysis was performed without ma huang included. Simple linear regression models were used to assess the trends (while excluding ma huang) in Fig. 3 . The model assumptions were assessed, and all models met the requirements. A t test was used to test the slope of the regression line to determine if it was significantly different from zero. The estimated annual rate of change from the regression model, denoted by Bm,^is reported along with the associated p value. Statistical significance was determined at alpha = 0.05. Person-identifying information was removed from NPDS data by the AAPCC before being made available to the investigators. This study was determined to be exempt by the Institutional Review Board at our institution.
Results

General Characteristics
From The three dietary supplements associated with the most deaths were other/ unknown multi-ingredient supplements (n =8),mahuang(n =5), and multi-botanicals without ma huang or Citrus aurantium (n = 4) ( Table 2) . Overall, 4.5% of exposures resulted in serious medical outcomes, and the majority (95.0%) of these serious outcomes occurred to individuals 6 years and older (Table 1) .
Clinical Effects and Therapies
The clinical effects resulting most frequently from dietary supplement exposures were tachycardia (4.0%, n = 10,890), vomiting (3.5%, n = 9669), nausea (2.9%, n = 8058), irritability (2.9%, n = 7849), drowsiness (2.3%, n = 6290), and dizziness (1.4%, n = 3873). More than one-half of dietary supplement exposures did not require therapy (56.5%, n = 155,339), but some required one (32.7%, n = 89,942), two (9.8%, n = 26,956), or three or more (1.0%, n = 2761) therapies. Decontamination was the most frequently administered therapy (36.7%, n = 100,865).
Dietary Supplement Characteristics
Miscellaneous supplements accounted for 43.9% of all dietary supplement exposures, followed by botanicals (31.9%), hormonal products (15.1%), and other supplements (5.1%) ( Table 3) . Amino acids, cultural medicines, and energy products each accounted for less than 2% of total dietary supplement exposures. The dietary supplement categories with the highest proportion of serious medical outcomes were energy products (10.8%), botanicals (10.8%), and cultural medicines (9.6%). Within the botanical category, yohimbe accounted for the largest proportion of serious medical outcomes (28.2%), followed by ma huang (16.5%), and multi-botanicals with ma huang (16.3%). Due to the relatively small number of exposures in the energy products category, it was not possible to determine which product subcategories were most commonly associated with serious medical outcomes.
Yohimbe, ma huang products, and energy product exposures are examined in greater detail (Table 4) and are discussed individually below. Homeopathic agents are also highlighted because of their association with more exposures than any other individual dietary supplement category (n = 98,998, 36.0%). 
Ma Huang Products
More than one-half of ma huang exposures were unintentional (54.2%) and occurred among females (57.5%) and individuals 6 years and older (61.6%) ( Table 4 ). Three percent (3.1%) of individuals with a ma huang product exposure were admitted to a critical care unit, and there were six deaths attributed to ma huang product exposure reported during the study period. Of 
Energy Products
Most energy product exposures occurred among males (60.1%) and were unintentional (61.7%) ( Table 4) . Individuals younger than 6 years old accounted for 44.7% of energy product exposures. Of all reported energy product exposures, 1.0% were admitted to a critical care unit. Energy products were associated with one death from 2010 through 2012.
Homeopathic Agents
Most homeopathic agent exposures occurred among children younger than 6 years old (92.7%, Table 3 ) and were unintentional (97.2%, n = 96,245). Nearly all homeopathic agent exposures were managed on-site without treatment in a HCF (93.8%, n = 92,900). Homeopathic agents accounted for 36.0% of dietary supplement exposures, but only 0.5% of homeopathic agent exposures experienced serious medical outcomes and 0.3% were admitted. Three deaths were attributed to homeopathic agent exposures (Table 2) . The numbers in italics are the values for the major categories of dietary supplements. The number that are not in italics are the values for the subcategories, or descriptions, within the major categories a Total includes cases with age unknown (n = 1250). Percentages may not sum to 100.0% due to rounding 
Discussion
Negative outcomes resulting from dietary supplement exposures have become an important public health problem due to widespread dietary supplement use and inadequate regulation of their availability, quality, and safety [2, 7, 9, 10, 12, 16] . This study defines the epidemiologic characteristics of these exposures. The majority of dietary supplement exposures occurred among children younger than 6 years old, which is consistent with previously published findings [8, 17] . As in previous studies, most of these exposures did not require treatment in a health care facility or result in long-term effects [10] . In this study, serious medical outcomes occurred more frequently among individuals 6 years and older. The less severe outcomes observed for exposures among young children may be a result of the higher proportion of unintentional and acute ingestions in this subgroup and more consistent reporting to PCCs of even minimal ingestions among young children [17] . In contrast, intentional and non-acute exposures may be more likely to go unreported among the older age group. Also, reported exposures among children younger than 6 years old were less often attributed to the dietary supplement categories that most frequently resulted in serious medical outcomes, compared with older individuals. Given that a greater proportion of the serious exposures occurred among the 6 years and older age group, future prevention efforts should include appropriate attention to this population. In addition, a few categories of dietary supplements, specifically yohimbe, products containing ma huang, cultural medicines, and energy products, were associated with higher rates of serious outcomes and merit special focus.
Yohimbe
Yohimbe is a botanical supplement used for a number of purposes, including to enhance male sexual performance [18] . Yohimbe is known to be associated with significant morbidity and mortality and has been reported to cause tachycardia, dysrhythmia, renal failure, seizure, and myocardial infarction [12, 19] . Our study found that almost 30% of reported yohimbe exposures resulted in moderate or major effects; 3.2% resulted in critical care unit admission, and there was one associated death. The potential toxicity of yohimbe exposures suggest the need for increased review and potential rule making by the FDA.
Ma Huang Products
Ma huang, also known as ephedra, is a botanical stimulant used to boost energy, improve alertness, lose weight, and improve athletic performance [12] . Ma huang is known to increase blood pressure and has been associated with myocardial infarction and stroke [20] . Calls to PCCs for ma huang product exposures decreased significantly during the study period. Although ma huang exposure rates began to decline prior to the FDA's 2004 ban of the substance, the agency's action was likely responsible for the continued and dramatic decrease in exposures [20] . In the current study, only one of the six ma huang-related deaths occurred after 2004. The decrease in ma huang product exposure calls to PCCs over the past decade provides support for using the NPDS not only to monitor trends in toxic exposures but also to gauge the availability and usage of substances nationally. The continued decline in ma huang-related exposures provides evidence of the effectiveness of FDA regulatory actions, and this strategy should be considered for other high-risk substances.
Energy Products
Energy drinks, advertised to increase energy and mental performance, contain one or more psychoactive ingredients, usually caffeine, but sometimes taurine, guarana, ginseng, Ginkgo biloba, L-carnitine, milk thistle, B vitamins, or other substances [21] . Energy products have been associated with dysrhythmias, seizure, and tachypnea, among other clinical effects [11] . In this study, 1.0% of exposures resulted in admission to a critical care unit and one exposure resulted in death. Many energy product exposures were unintentional and occurred among young children. These findings corroborate the need for improved energy product regulation, child-resistant packaging, and caregiver education [11, 22] .
Homeopathic Agents
Homeopathic agents accounted for 36% of all exposures and 97% of those exposed were among children younger than 6 years old. Homeopathic agents are frequently used to treat conditions such as respiratory problems, eczema, pain, colic, migraines, attention-deficit hyperactivity disorder, and asthma among children [23] [24] [25] [26] [27] [28] . The rate of exposure to homeopathic agents increased by more than 200% from 2000 to 2010 and then decreased by 18% from 2010 to 2012. The reasons for this observed decrease are uncertain. Reported exposures were largely benign and usually managed on-site; however, there were three deaths associated with homeopathic agents in this study.
Study Limitations
This study has several limitations. NPDS data are based on selfreported information provided by callers, which cannot be completely verified by PCCs or the AAPCC. Because reporting to the NPDS is voluntary, this study underestimates the number of dietary supplement exposures in the US. Exposures to some dietary supplements may be more likely to be reported to the NPDS than others. Dietary supplement exposures among women and young children may be reported to PCCs more frequently than those among men and older children or adults [8, 10] . This potential reporting bias should be considered when interpreting results. This study may also underestimate dietary supplement toxicity because 3.7% of medical outcomes were potentially toxic but could not be followed. Reported exposures do not necessarily represent a poisoning or overdose. In addition, calls to PCCs usually involve acute exposures; therefore, NPDS data likely do not reflect the true prevalence of chronic toxicity from dietary supplements. Finally, fatalities are reviewed in the NPDS using a three-tiered process (often including review of autopsy results) and substances are classified regarding their relative contribution to fatality, including undoubtedly related, probably related, contributory, and not related; however, this study does not fully elaborate on the classification of the reported deaths. Despite these limitations, NPDS data are entered by highly qualified poison experts using strict quality controls and case follow-up protocols. The NPDS offers an inclusive and detailed database for investigating dietary supplement exposures in the US.
Conclusions
There was an overall increase in the rate of dietary supplement exposures reported to US PCCs from 2000 through 2012. Although the majority of dietary supplement exposures did not require treatment at a HCF or result in serious medical outcomes, two categories of dietary supplements were notable for their adverse consequences: yohimbe and energy products. Our results demonstrate the need for FDA regulation of yohimbe and energy products in the US as was done successfully with ma huang products in 2004.
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